Portal de Periódicos da CAPES

B‐cell lymphoma in a girl with ataxia teleangiectasia (A‐T) treated with rituximab monotherapy

2005; Wiley; Volume: 46; Issue: 4 Linguagem: Inglês

10.1002/pbc.20548

1545-5017

Gabriele Kropshofer, Goetz Wehl, Andreas Klein‐Franke, Wolfgang Högler, Bernhard Meister,

DNA Repair Mechanisms

Pediatric Blood & CancerVolume 46, Issue 4 p. 528-529 Letter to the Editor B-cell lymphoma in a girl with ataxia teleangiectasia (A-T) treated with rituximab monotherapy Gabriele Kropshofer MD, Corresponding Author Gabriele Kropshofer MD [email protected] Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaDepartment of Pediatrics & Adolescent Medicine, Medical University Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria.===Search for more papers by this authorGötz Wehl MD, Götz Wehl MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorAndreas Klein-Franke MD, Andreas Klein-Franke MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorWolfgang Högler MD, Wolfgang Högler MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorBernhard Meister MD, Bernhard Meister MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this author Gabriele Kropshofer MD, Corresponding Author Gabriele Kropshofer MD [email protected] Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaDepartment of Pediatrics & Adolescent Medicine, Medical University Innsbruck, Anichstraße 35, A-6020 Innsbruck, Austria.===Search for more papers by this authorGötz Wehl MD, Götz Wehl MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorAndreas Klein-Franke MD, Andreas Klein-Franke MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorWolfgang Högler MD, Wolfgang Högler MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this authorBernhard Meister MD, Bernhard Meister MD Department of Pediatrics, Division of Pediatric Oncology and Hematology, Medical University Innsbruck, Innsbruck, AustriaSearch for more papers by this author First published: 25 August 2005 https://doi.org/10.1002/pbc.20548Citations: 14Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Sara G, Becker-Catania X, Richard A, et al. Ataxia–Teleangiectasia. Adv Exp Med Biol 2001; 495: 191–198. PubMedWeb of Science®Google Scholar 2 Swift M, Morrell D, Cromartie E, et al. The incidence and gene frequency of ataxia teleangiectasia in the United States. Am Hum Genet 1986; 39: 573–583. CASPubMedWeb of Science®Google Scholar 3 Sandoval C, Swift M. Hodgkin Disease in Ataxia-Teleangiectasia patients with poor outcomes. Med Pediatr Oncol 2003; 40: 162–166. 10.1002/mpo.10251 CASPubMedWeb of Science®Google Scholar 4 Morrel D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia teleangiectasia. J Natl Cancer Inst 1986; 77: 89–92. PubMedWeb of Science®Google Scholar 5 Hecht F, Hecht BK. Cancer in ataxia teleangiectasia patients. Cancer Genet Cytogenet 1990; 46: 9–19. 10.1016/0165-4608(90)90003-S CASPubMedWeb of Science®Google Scholar 6 Swift M, Morrel D, Massey RB, et al. Incidence of cancer in 161 families affected by ataxia–teleangiectasia. N Engl J Med 1991; 325: 1831. 10.1056/NEJM199112263252602 CASPubMedWeb of Science®Google Scholar 7 Plosker GL, Figgit DP. Rituximab: A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Drugs 2003; 63: 803–843. 10.2165/00003495-200363080-00005 CASPubMedWeb of Science®Google Scholar 8 Seidemann K, Tiemann M, Henze G, et al. Therapy for non- Hodgkin lymphoma in chidren with primary immunodeficiency: Analysis of 19 patients from the BFM trial. Med Pedatr Oncol 1999; 33: 536–544. 10.1002/(SICI)1096-911X(199912)33:6 3.0.CO;2-Z CASPubMedWeb of Science®Google Scholar Citing Literature Volume46, Issue4April 2006Pages 528-529 ReferencesRelatedInformation